Product
Arden regenerative care bay receives its first approvals
Regulators in the Netherlands, the United Kingdom and eleven other markets have approved Arden for adult patients in critical care.
LEIDEN, Netherlands, 8 June 2021
TriOptimum Medical Systems today announced that the Arden regenerative care bay has been approved for clinical use in thirteen markets, including the Netherlands and the United Kingdom, for adult patients in critical care following severe trauma, burns or major surgery.
Arden is the result of eleven years of development by Medical Systems and TriOptimum Research Laboratories in Leiden. Its first installations, at four university hospitals, will begin in September.
Arden does one thing: it helps a badly injured patient get back to who they were. Everything about it, from the monitoring to the clinician’s override, is built around that.
About TriOptimum
TriOptimum Corporation (NYSE: TRIO) is a diversified technology company with six business segments: Security Products, Medical Systems, Network Services, Orbital & Research Systems, Resources & Materials and Agrisystems. Founded in Halsworth, England, in 1951, TriOptimum employs 118,400 people in 47 countries and reported revenue of $41.27 billion in 2025.
Contacts
Media
Corporate Communications
press@trioptimumcorp.com
+44 113 496 0731